Overview of monthly costs of lung cancer treatment drug sotoraxib

Sotorasiib, an innovative drug targeting specific lung cancer types, has shown significant efficacy in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) carryingKRAS G12C mutations. However, the cost of treatment is always a major concern for patients. The purpose of this article is to provide a rough estimate of the monthly cost of Sotolaxib based on its recommended dosage and the different versions on the market.

The standard dosage of sotoraxib is 960 mg orally daily , which is eight 120 mg tablets. But the cost of different versions of the drug varies significantly.

First, let’s look at the original drug version. Original drugs are usually priced higher. Taking the Hong Kong version of sotorasibu as an example, a box of 120mg*240 tablets costs about 40,000 to 50,000 yuan. Since patients need to take one box per month, the monthly treatment costs also reach this level, which is a heavy burden for many patients.

Next, we consider generic versions. Among them, Lucius Pharmaceuticals’ sotoracib is very popular in the market. This version has a box size of 120mg*56 tablets and sells for about one to two thousand yuan. Although the price per tablet is low, one box only provides about a week's worth of treatment, so you'll need about four boxes a month. Even so, the total monthly cost is only around a few thousand to ten thousand yuan, which is far lower than the original version.

To sum up, the monthly treatment cost of Sotolaxib varies depending on the version. The original version of the drug has reliable efficacy, but its high price may prohibit some patients. The generic version is more affordable, but patients need to be careful when choosing and ensure the source of the drug is reliable to ensure the safety and effectiveness of the treatment.